Error 404 - Not Found

Suggestions

Celebrex ( Celecoxib ) Drug Information: Uses, Side Effects, Drug Feb 19, 2009 Learn about the prescription medication Celebrex ( Celecoxib ), Investigations : Blood potassium increased, blood sodium increased, blood testosterone decreased .. Patients should be informed of the warning signs and symptoms of In Canada , you may call Health Canada at 1-866-234-2345.

Health Canada Issues Celebrex ® Warning « ssem.com Health Canada says Pfizer can't market Celebrex ® for the treatment of Familial Adenomatous Polyposys, a disease "highly predictive" of colorectal cancer.

Women and Health Protection Documents - Complaint Letter to Health Canada has sent out a safety advisory to Canadian physicians and In the U.S. Celebrex has a black box warning on its label, warning messages from this ad campaign while it is under investigation ? [7] FDA exposes problems with Celebrex and Bextra adverts even before DTC (direct-to-consumer) halt.

Development through Celebrex Recall Debate - Learn the History On November 4, 2004 a class action suit was filed in Canada where the group the federal health department of Canada confirmed 14 Celebrex related deaths. the FDA issues a warning letter to Pfizer for misrepresentation of Celebrex . Celebrex can lead to serious heart problems - Learn about them here

CELEBREX -Product Monograph - PRODUCT MONOGRAPH celecoxib Capsules File Format: PDF/Adobe Acrobat - Quick View Individuals with the above medical problems are at risk of a severe reaction . warning symptoms, in patients treated with NSAIDs, such as CELEBREX . .. Therefore, in women who have difficulties conceiving, or who are undergoing investigation of To monitor drug safety, Health Canada through the

Bextra Product Recall Canada Health quickly followed suit and asked Pfizer to recall Bextra from Canadian shelves. warning against using the medication for patients with cardiac problems . Bextra, Celebrex Cases Are Settling Form the Health Blog of the Wall owner, DA suits; AG investigations ; Federal Grand Jury; House inquiry

Celebrex Approved In Canada For Arthritis Celebrex received priority review from Health Canada and will be available by 20000 Canadians experience severe problems such as GI perforations and bleeding. serious GI tract ulcerations can occur without warning symptoms.

Canadian Adverse Reaction Newsletter, Volume 12, Issue 3, July 2002 by AR Reporting - 2002 - Related articles More data from ongoing investigations are still required to assess the . In an effort to clarify these issues Health Canada has posted an "It's May 16, Longdan, Warning not to consume Longdan and Lung Tan Xie Gan Products - consumer information ( celecoxib ), Important drug safety information on Celebrex

Canadian Adverse Reaction Newsletter, Volume 12, Issue 2, April 2002 by RA Reactions - 2002 - Related articles In This Issue Marketed Health Products Directorate Rofecoxib (Vioxx) and celecoxib ( Celebrex ) are believed to be selective COX-2 Further investigations are required to assess possible cardiovascular risks of COX-2 inhibitors. labeling changes and required that products carry a warning to consumers not

CBC News - Health - Arthritis drug Celebrex linked to higher heart RELATED STORY: Pfizer shares pounded on news of Celebrex heart risk FAINT WARNING A CBC investigation of Canada's adverse drug reaction surveillance